Aditya Vyas

Aditya Vyas

Auto-generated profile, based on publicly available information

Aditya Vyas

School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2024 in Environmental Research Letters
Verified
Journal Article
Open access
AVAditya Vyas
Aditya Vyas
AWArthur Wyns
Arthur Wyns
PBPaul Beggs
Paul Beggs
YZYing Zhang
Ying Zhang

16 November 2018 in Thorax
Verified
Conference Paper
Closed access
PDF file
CSClaire Diane Slinger
Claire Diane Slinger
AVA Vyas
A Vyas
RSRj Slinger
Rj Slinger
JBJ Blakemore
J Blakemore
Introduction Inducible laryngeal obstruction (Ilo) is defined as an inappropriate adduction of the larynx on inspiration. Speech and language therapy (SLT) is viewed as the cornerstone of treatment of Ilo. Clinical consensus indicates that the optimal number of SLT sessions is between four and six. Our previous research has shown that% Forced Vital Capacity (% FVC) is a reliable predictor of Ilo in patients with breathlessness referred to our tertiary airways service (ERS Congress, 2017). In our current research, we aimed to investigate whether% FVC and other patient factors can predict improvement in Ilo symptoms following SLT intervention. Methods Data were analysed from 59 patients presenting to our service with symptoms of breathlessness. All had a diagnosis of Ilo via videolaryngoscopy and received SLT treatment. Analyses investigated relationships between improvement on Ilo symptoms and% FVC as well as other patient details. The VCDQ, a validated questionnaire measuring Ilo symptoms and response to SLT, was used pre- and post-therapy to assess improvement. Results VCDQ scores decreased following SLT for forty (68%) patients, demonstrating improvement. Of patients who improved, the mean number of SLT sessions was four, with the majority (60%) attending three to five sessions. No relationships were found between post-SLT improvement on the VCDQ and patient factors including age, gender, and potential co-morbidities such as asthma, GORD and rhinitis. There was a significant relationship between% FVC and VCDQ improvement (r=0.346, n=51, p=0.01). A binary logistic regression assessed the impact of% FVC on VCDQ improvement. The model was significant (χ 2=6.337 (1, n=59) p=0.012), and explained between 12% and 16% of the variance in improvement, correctly classifying 69% of cases. Patients with higher% FVC were five times more likely to show improvement on the VCDQ following SLT. Conclusions In line with clinical consensus, 3 to 5 sessions of SLT were sufficient to lead to improvements on VCDQ scores for the majority of patients. Patient demographic data did not predict improvements in Ilo following SLT, however% FVC may be a predictor of good treatment response to SLT for Ilo.

13 March 2026 in Communications Sustainability
Verified
Journal Article
Open access
PDF file
JWJake Thomas Warton Williams
Jake Thomas Warton Williams
PCPhilomena Colagiuri
Philomena Colagiuri
PBPaul Beggs
Paul Beggs
KDKim Robin van Daalen
Kim Robin van Daalen
AVAditya Vyas
Aditya Vyas
YZYing Zhang
Ying Zhang
The annual United Nations Framework Convention on Climate Change Conference of the Parties convenes thousands of delegates from around the world to negotiate international climate policy, with participation relying heavily on long-distance air travel. Here, we estimate greenhouse gas emissions from travel by Party and Observer State attendees to every conference from 1995 to 2024 using the carbon R package and two datasets: a complete list of individual attendees from the first through the twenty-ninth conference, and global flight-route data (OpenFlights, 2014). Indirect emissions and well-to-tank emissions were included. Total emissions per conference were estimated by multiplying emissions per person per country by the total number of attendees and summing across countries. Emissions totalled 710,282 tonnes of carbon-dioxide equivalent over the study period, increasing by 2500% from the first conference (2959 tonnes) to the twenty-ninth (76,931 tonnes). Emissions per attendee were higher for conferences farther from Europe.

12 November 2019 in Thorax
Verified
Conference Paper
Closed access
PDF file
CSClaire Diane Slinger
Claire Diane Slinger
HWH Wilson
H Wilson
AVA Vyas
A Vyas
RSR Slinger
R Slinger
Introduction Symptoms of breathlessness in people referred to a Tertiary Airways and Severe Asthma service may be due to a variety of treatable conditions, including asthma, inducible laryngeal obstruction (Ilo) and breathing pattern disorder (BPD). Previous research has shown overlap between asthma and Ilo (Low et al, 2011), and between asthma and BPD (Boulding et al., 2016). In clinical practice, overlap between Ilo and BPD is also common, but this has not been consistently shown in research. Aims and objectives To explore the incidence of Ilo, asthma and BPD and the overlap between these conditions in a sample of patients referred to a tertiary airways service, and to investigate patient characteristics associated with each condition. Methods Patient notes were reviewed for people referred to a tertiary airways service for symptoms of breathlessness over an 18 month period. Assessment information was collated for patients (n=306) diagnosed with asthma, Ilo and/or BPD. Results Of the 306 patients, 235 (77%) were diagnosed with Ilo via videolaryngoscopy, 177 (58%) were diagnosed with asthma, and 83 (27%) were diagnosed with BPD. There was significant overlap between the three conditions, with 186 patients (52%) having at least two conditions. The most common overlap was between asthma and Ilo (30% of patients), followed by Ilo and BPD (11%). In contrast, only 3% of patients in this sample had both asthma and BPD. All three conditions were seen in 9% of patients. A visual representation of overlap is presented in figure 1 below: Of the three conditions, Ilo most commonly co-occurred with asthma, whilst BPD most commonly co-occurred with Ilo. When BPD co-occurred with asthma, this was most commonly seen together with Ilo. Conclusions This study showed high levels of overlap between conditions that can contribute to symptoms of breathlessness. This emphasises the importance of a multi-professional assessment and optimisation of comorbid treatable traits, such as Ilo and BPD. It may also serve as a reminder for a timely referral for specialist assessment and management of treatable traits to avoid the potential of morbidity, increased healthcare utilisation and over-medication in severe and difficult to treat asthma.

12 May 2026
Verified
Book Chapter
Open access
IHIvan Hanigan
Ivan Hanigan
AVAditya Vyas
Aditya Vyas

28 October 2026 in Medical Journal of Australia
Verified
Journal Article
Open access
PDF file
PBPaul Beggs
Paul Beggs
TSTanya Singh
Tanya Singh
HBHilary Bambrick
Hilary Bambrick
NANicolas Borchers Arriagada
Nicolas Borchers Arriagada
KBKathryn Bowen
Kathryn Bowen
MRMarina B. Romanello
Marina B. Romanello
The Medical Journal of Australia ( MJA )– Lancet Countdown on health and climate change in Oceania was established in 2017 and produced its first regional assessment in 2018 and annual updates from 2019 to 2025. It examines five broad domains: (1) health hazards, exposures and impacts; (2) adaptation, planning and resilience for health; (3) mitigation actions and health co‐benefits; (4) economics and finance; and (5) public and political engagement. In this, the eighth report of the MJA – Lancet Countdown, we track an extensive suite of indicators across these five domains, accessing and presenting the latest data and further refining and developing our analyses. Our analyses show that exposure of infants and older adults to heatwaves in Australia and Aotearoa New Zealand has increased substantially over the past decade due to climate change, and half of the 16,230 young Australians aged 14–19 years surveyed reported that they are worried or sad about the impacts of climate change, including its threat to people, and about 1 in 7 reported that such feelings are negatively affecting their daily life. Increasing heat‐related mortality alone is placing a large economic burden on Australians, with associated inflation‐adjusted costs over the period 2021–2025 being more than double what they were at the start of the century, now averaging an estimated US$1.49 billion per year nationally. In other areas, some progress is being made. New Zealand's Health National Adaptation Plan 2024–2027, published in October 2024, lays the foundation for building climate resilience within its health system, while acknowledging the environmental and social determinants of health that apply more broadly. The provision of climate services to the health sector in both Australia and New Zealand is categorised as advanced. In Australia, healthcare‐related greenhouse gas emissions generally declined from 2016 to 2023. In conclusion, the threat to physical and mental health from climate change continues to grow. Despite pockets of progress, Australia and New Zealand have a long way to go to adequately mitigate and adapt to climate change, and in so doing not only avoid health impacts but seize the opportunity for generational health gains. Important opportunities have been lost, such as the failed attempts to amend Australia's Climate Change Act 2022 to ‘require decision‐makers to consider the health and well‐being of children in Australia when making significant decisions’. In 2026, Australia is in the spotlight as President of Negotiations for the United Nations Climate Change Conference (COP31)—an unprecedented opportunity for the Australian Government to push through the sizable step change in global climate action that is now critically required.